SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amedica Corporation on April 13, 2017. The report addresses a material accounting error identified during the preparation of the fiscal year 2016 consolidated financial statements. The filing specifically concerns the unaudited condensed consolidated financial statements previously reported in the Form 10-Q for the quarter ended September 30, 2016.
Key Financial Metrics and Adjustments
The filing discloses a restatement of prior period results due to a failure to record a one-time non-cash charge related to the accretion of a discount on the conversion of Series A Preferred Stock.
- Adjustment Amount: An additional non-cash deemed dividend charge of $3,779,000 was identified.
- Total Deemed Dividend: Increased from a previously reported $2,499,000 to a corrected $6,278,000.
- Net Loss (3 months ended Sept 30, 2016): Adjusted to $10,616,000.
- Net Loss (9 months ended Sept 30, 2016): Adjusted to $19,068,000.
- EPS Impact (3 months): Net loss per share increased from $0.30 to $0.46.
- EPS Impact (9 months): Net loss per share increased from $0.97 to $1.21.
The filing text does not provide current period revenue, operating cash flow, debt levels, or liquidity metrics; it focuses exclusively on the restatement of historical net loss figures.
Material Changes Versus Prior Period
The material change is the restatement of the Q3 2016 financial results. The previously issued Form 10-Q filed on November 14, 2016, is no longer reliable. The primary change is the recognition of a larger non-cash charge, which significantly increased the reported net loss and loss per share for both the three-month and nine-month periods ended September 30, 2016.
Guidance, Outlook, and Risks
Management Commentary: The Audit Committee concluded that the prior financial statements should no longer be relied upon. The company has discussed these matters with its independent registered public accounting firm, BDO USA, LLP.
Corrective Action: The company will restate the interim unaudited condensed consolidated financial statements in an amended Quarterly Report on Form 10-Q/A.
Risks: The filing highlights the risk of historical financial misstatement due to accounting errors regarding preferred stock conversion discounts.
Key Facts for Investor Verification
- Verify the upcoming amended Form 10-Q/A for the quarter ended September 30, 2016, to confirm the restated financial figures.
- Confirm the specific accounting guidance reassessed by the company regarding the accretion of the discount on Series A Preferred Stock.
- Review the impact of the $3,779,000 non-cash charge on the company's overall capital structure and equity position.
- Note that the filing date is April 13, 2017, but the signature date is April 18, 2017.